famotidine has been researched along with Hyperammonemia in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Hyperammonemia: Elevated level of AMMONIA in the blood. It is a sign of defective CATABOLISM of AMINO ACIDS or ammonia to UREA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogawa, M | 1 |
| Shinjo, T | 1 |
| Tei, Y | 1 |
| Morita, T | 1 |
1 other study available for famotidine and Hyperammonemia
| Article | Year |
|---|---|
Uncommon underlying etiologies of reversible delirium in terminally ill cancer patients.
Topics: Aged; Anti-Ulcer Agents; Delirium; Famotidine; Female; Humans; Hyperammonemia; Male; Neoplasms; Pall | 2006 |